Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 113 Results

Title
Intervention Indication Therapeutic Area Year Actions
Pembrolizumab with or without olaparib following pembrolizumab with chemoradiation therapy for previously untreated, advanced, stage III non-small-cell lung cancer Chemoradiotherapy , Olaparib (Lynparza; MK-7339; AZD2281; AZD-2281) , Pembrolizumab (Keytruda; MK-3475) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2023 View  |  Download
Pembrolizumab with or without standard adjuvant therapy after resection for nonsmall-cell lung cancer - adjuvant Pembrolizumab (Keytruda; MK-3475) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2020 View  |  Download
Pembrolizumab with stereotactic body radiotherapy for unresected stage I or II non-small cell lung cancer Pembrolizumab (Keytruda; MK-3475) , Stereotactic body radiotherapy Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2022 View  |  Download
Pembrolizumab-vibostolimab for previously untreated non-small-cell lung cancer (NSCLC) Pembrolizumab-vibostolimab (MK-7684; MK7684A; Vibostolimab) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2023 View  |  Download
Pembrolizumab-vibostolimab with etoposide and platinum chemotherapy for previously untreated extensive-stage small cell lung cancer Etoposide , Pembrolizumab-vibostolimab (MK-7684; MK7684A; Vibostolimab) , Platinum-based chemotherapy Small-cell lung cancer (SCLC) Lung and Respiratory Cancer 2023 View  |  Download
Plinabulin in addition to docetaxel for advanced, metastatic non-small-cell lung cancer - second line or greater Docetaxel (Taxotere; docetaxel trihydrate; docetaxel anhydrous) , Plinabulin (BPI-2358) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2020 View  |  Download
Pralsetinib for RET-fusion positive metastatic non-small-cell lung cancer Pralsetinib (BLU-667; Gavreto) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2020 View  |  Download
Ramucirumab in addition to erlotinib for EGFR mutation-positive metastatic non-small-cell lung cancer Erlotinib (Tarceva; erlotinib hydrochloride) , Ramucirumab (Cyramza) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2019 View  |  Download
Repotrectinib for treating advanced or metastatic nonsmall-cell lung cancer with ROS1-postive mutation Repotrectinib (TPX 0005) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2023 View  |  Download
Retifanlimab with chemotherapy for previously untreated metastatic non-small-cell lung cancer Endocrine therapy , Ribociclib (Kisqali; LEE-011; ribociclib succinate) Breast cancer , Non-small-cell lung cancer (NSCLC) Breast Cancer , Lung and Respiratory Cancer 2024 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications